Blue Jet Healthcare has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise as much as Rs 2,100 crore through an initial public offering (IPO).
Kotak Mahindra Capital Company, ICICI Securities, and J.P. Morgan India are the books running lead managers to the issue. The equity shares are proposed to be listed on BSE and NSE.
The Mumbai-based Blue Jet Healthcare, is a specialty pharmaceutical and healthcare ingredient and intermediate company, offering niche products targeted towards innovator pharmaceutical companies and multinational generic pharmaceutical companies.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1644.80 |
| Dr. Reddys Lab | 1210.40 |
| Cipla | 1205.20 |
| Zydus Lifesciences | 907.80 |
| Lupin | 2319.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: